Garry Michael Kann
Corporate Officer/Principal presso ENDONOVO THERAPEUTICS, INC.
Profilo
Garry Michael Kann is currently the Head of Corporate Development at Endonovo Therapeutics, Inc. and a Partner at The Firebird Partnership Ltd.
He obtained an undergraduate degree from Kean University.
Posizioni attive di Garry Michael Kann
| Società | Posizione | Inizio |
|---|---|---|
| ENDONOVO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2022 |
The Firebird Partnership Ltd.
 The Firebird Partnership Ltd. Financial ConglomeratesFinance The Firebird Partnership Ltd. provides investment services. The private company is based in Winchester, UK. The British company was founded in 2020 by Stewart Alexander Lambert, Ian Stuart Finlay. | Corporate Officer/Principal | - |
Formazione di Garry Michael Kann
| Kean University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ENDONOVO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
The Firebird Partnership Ltd.
The Firebird Partnership Ltd. Financial ConglomeratesFinance The Firebird Partnership Ltd. provides investment services. The private company is based in Winchester, UK. The British company was founded in 2020 by Stewart Alexander Lambert, Ian Stuart Finlay. | Finance |
- Borsa valori
- Insiders
- Garry Michael Kann
